• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痛风石的存在与痛风患者肾功能的快速下降有关。

Presence of tophi is associated with a rapid decline in the renal function in patients with gout.

作者信息

Oh Yoon-Jeong, Moon Ki Won

机构信息

Division of Rheumatology, Department of Internal Medicine, Kangwon National University School of Medicine, 156, Baengnyeong-ro, Chuncheon-si, Gangwon-do, Republic of Korea.

出版信息

Sci Rep. 2021 Mar 11;11(1):5684. doi: 10.1038/s41598-021-84980-6.

DOI:10.1038/s41598-021-84980-6
PMID:33707563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7952381/
Abstract

We aimed to compare clinical characteristics of patients with and without tophi at the time of the diagnosis of gout and investigate the association of tophi and renal function in gout patients. The patients who were first diagnosed with gout at the Kangwon National University Hospital were retrospectively studied. Patients were divided into 2 groups according to the presence of tophi at the diagnosis. We compared clinical characteristics and the progression of renal dysfunction between the two groups. Of 276 patients, 66 (25.5%) initially presented with tophi. Tophi group was older, had a longer symptom duration, and a higher prevalence of multiple joint involvement than those without tophi. In multivariate logistic regression analysis, prolonged symptom duration and multiple joint involvement were significantly associated with increased risk of formation of tophi. The decline in the eGFR was more prominent in patients with tophi than in those without (- 4.8 ± 14.5 vs. - 0.7 ± 11.9 ml/min/1.73 m/year, respectively; P = 0.039). The presence of tophi was significantly associated with a rapid decline in the eGFR (β = - 0.136; P = 0.042). In conclusion, the presence of tophi was associated with a rapid declining renal function. Therefore, an early diagnosis and closely monitoring of renal function might be important in gout patients with tophi.

摘要

我们旨在比较痛风诊断时有无痛风石患者的临床特征,并研究痛风患者中痛风石与肾功能的关系。对在江原国立大学医院首次诊断为痛风的患者进行回顾性研究。根据诊断时是否存在痛风石将患者分为两组。我们比较了两组患者的临床特征和肾功能不全的进展情况。在276例患者中,66例(25.5%)初诊时即有痛风石。痛风石组患者年龄更大,症状持续时间更长,多关节受累的患病率高于无痛风石患者。多因素逻辑回归分析显示,症状持续时间延长和多关节受累与痛风石形成风险增加显著相关。痛风石患者的估算肾小球滤过率(eGFR)下降比无痛风石患者更明显(分别为-4.8±14.5与-0.7±11.9 ml/min/1.73m²/年;P=0.039)。痛风石的存在与eGFR快速下降显著相关(β=-0.136;P=0.042)。总之,痛风石的存在与肾功能快速下降有关。因此,对于有痛风石的痛风患者,早期诊断并密切监测肾功能可能很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c002/7952381/54cc1a859500/41598_2021_84980_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c002/7952381/54cc1a859500/41598_2021_84980_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c002/7952381/54cc1a859500/41598_2021_84980_Fig1_HTML.jpg

相似文献

1
Presence of tophi is associated with a rapid decline in the renal function in patients with gout.痛风石的存在与痛风患者肾功能的快速下降有关。
Sci Rep. 2021 Mar 11;11(1):5684. doi: 10.1038/s41598-021-84980-6.
2
Risk factors of ultrasound-detected tophi in patients with gout.痛风患者超声下尿酸盐结晶的危险因素。
Clin Rheumatol. 2020 Jun;39(6):1953-1960. doi: 10.1007/s10067-020-04947-2. Epub 2020 Feb 15.
3
Metabolic characteristics and renal dysfunction in 65 patients with tophi prior to gout.65例痛风前痛风石患者的代谢特征及肾功能不全
Clin Rheumatol. 2017 Aug;36(8):1903-1909. doi: 10.1007/s10067-017-3663-0. Epub 2017 May 10.
4
Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout.早发型青少年痛风石患者代谢成分与肾功能的临床特征及相关性研究。
J Rheumatol. 2014 Sep;41(9):1878-83. doi: 10.3899/jrheum.131240. Epub 2014 Aug 1.
5
Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study.与中国痛风患者皮下痛风石形成相关的临床特征:一项回顾性研究。
Clin Rheumatol. 2018 May;37(5):1359-1365. doi: 10.1007/s10067-017-3969-y. Epub 2018 Jan 22.
6
Renal function in minahasanese patients with chronic gout arthritis and tophi.米纳哈萨族慢性痛风性关节炎和痛风石患者的肾功能
Acta Med Indones. 2005 Apr-Jun;37(2):61-65.
7
Presence of tophi is a predictive factor of arterial stiffness in patients with gout.有痛风石存在是预测痛风患者动脉僵硬的一个因素。
Rheumatol Int. 2019 Jul;39(7):1249-1255. doi: 10.1007/s00296-019-04313-9. Epub 2019 Jun 1.
8
Intradermal tophi in gout: a case-control study.痛风中的皮内痛风石:一项病例对照研究。
J Rheumatol. 1999 Jan;26(1):136-40.
9
Clinical characteristics and risk factors associated with bone erosion in patients with tophi.与痛风石患者骨侵蚀相关的临床特征和危险因素。
Adv Rheumatol. 2024 Mar 4;64(1):18. doi: 10.1186/s42358-023-00336-w.
10
Comorbidities in patients with gout.痛风患者的合并症
Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1045-50. doi: 10.1080/15257770.2011.596499.

引用本文的文献

1
Targeting Hyperuricemia and NLRP3 Inflammasome in Gouty Arthritis: A Preclinical Evaluation of Allopurinol and Disulfiram Combination Therapy.靶向痛风性关节炎中的高尿酸血症和NLRP3炎性小体:别嘌醇与双硫仑联合治疗的临床前评估
Pharmaceuticals (Basel). 2025 May 21;18(5):762. doi: 10.3390/ph18050762.
2
Characteristics and Management of Uncontrolled Gout Prior to Pegloticase Therapy: A 2-year Claims Analysis.培戈洛酶治疗前未控制痛风的特征与管理:一项为期2年的索赔分析。
Rheumatol Ther. 2025 Feb;12(1):37-51. doi: 10.1007/s40744-024-00723-9. Epub 2024 Nov 14.
3
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review.

本文引用的文献

1
Association of Specific Comorbidities with Monosodium Urate Crystal Deposition in Urate-Lowering Therapy-Naive Gout Patients: A Cross-Sectional Dual-Energy Computed Tomography Study.初治痛风患者中特定合并症与尿酸盐结晶沉积的关联:一项横断面双能计算机断层扫描研究
J Clin Med. 2020 May 1;9(5):1295. doi: 10.3390/jcm9051295.
2
Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008-2012).高尿酸血症及其与西北地区肥胖和血脂异常的关系:来自新疆心血管风险调查(CRS 2008-2012)的结果。
Lipids Health Dis. 2020 Apr 1;19(1):58. doi: 10.1186/s12944-020-01211-z.
3
新兴的降尿酸药物和痛风的药物治疗策略:一篇叙述性综述。
Drugs. 2023 Nov;83(16):1501-1521. doi: 10.1007/s40265-023-01944-y. Epub 2023 Oct 11.
4
When Gout Is in Doubt: A Curious Case of Lupus Nephritis.当痛风存疑时:一例罕见的狼疮性肾炎病例
Cureus. 2023 Aug 19;15(8):e43737. doi: 10.7759/cureus.43737. eCollection 2023 Aug.
5
Analysis of Metabolites in Gout: A Systematic Review and Meta-Analysis.痛风代谢产物分析:系统评价和荟萃分析。
Nutrients. 2023 Jul 14;15(14):3143. doi: 10.3390/nu15143143.
6
Osteogenic Potential of Monosodium Urate Crystals in Synovial Mesenchymal Stem Cells.尿酸单钠晶体在滑膜间充质干细胞中的成骨潜能。
Medicina (Kaunas). 2022 Nov 24;58(12):1724. doi: 10.3390/medicina58121724.
7
Research progress of risk factors and early diagnostic biomarkers of gout-induced renal injury.痛风相关性肾损伤的危险因素及早期诊断生物标志物的研究进展。
Front Immunol. 2022 Sep 20;13:908517. doi: 10.3389/fimmu.2022.908517. eCollection 2022.
8
Analysis of Risk Factors for Changes in the Renal Two-Dimensional Image in Gout Patients.痛风患者肾脏二维图像变化的危险因素分析
Int J Gen Med. 2021 Oct 5;14:6367-6378. doi: 10.2147/IJGM.S336220. eCollection 2021.
Comorbidities in gout and hyperuricemia: causality or epiphenomena?
痛风和高尿酸血症的共病:因果关系还是偶然现象?
Curr Opin Rheumatol. 2020 Mar;32(2):126-133. doi: 10.1097/BOR.0000000000000691.
4
Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study.与中国痛风患者皮下痛风石形成相关的临床特征:一项回顾性研究。
Clin Rheumatol. 2018 May;37(5):1359-1365. doi: 10.1007/s10067-017-3969-y. Epub 2018 Jan 22.
5
Chronic tophaceous gout as the first manifestation of gout in two cases and a review of the literature.慢性痛风石性痛风作为痛风的两种首发表现病例并文献复习。
Semin Arthritis Rheum. 2018 Jun;47(6):843-848. doi: 10.1016/j.semarthrit.2017.11.006. Epub 2017 Nov 27.
6
The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Population-based Study over 20 Years.痛风发病率上升和合并症负担增加:一项超过 20 年的基于人群的研究。
J Rheumatol. 2018 Apr;45(4):574-579. doi: 10.3899/jrheum.170806. Epub 2017 Dec 15.
7
Clinically-evident tophi are associated with reduced muscle force in the foot and ankle in people with gout: a cross-sectional study.一项横断面研究:痛风患者中临床上明显的痛风石与足踝部肌肉力量减弱有关。
J Foot Ankle Res. 2017 Jun 19;10:25. doi: 10.1186/s13047-017-0207-4. eCollection 2017.
8
Management of Gout and Hyperuricemia in CKD.慢性肾脏病患者痛风和高尿酸血症的管理
Am J Kidney Dis. 2017 Sep;70(3):422-439. doi: 10.1053/j.ajkd.2017.01.055. Epub 2017 Apr 26.
9
Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?痛风患者血清尿酸治疗目标概述:为何低于6mg/dL?
Postgrad Med. 2016 Sep;128(7):706-15. doi: 10.1080/00325481.2016.1221732. Epub 2016 Aug 25.
10
Gout.痛风
Lancet. 2016 Oct 22;388(10055):2039-2052. doi: 10.1016/S0140-6736(16)00346-9. Epub 2016 Apr 21.